ArticleAAPS PharmSciTech2026
Development of an Injectable Boronic Ester Nanocomposite Hydrogel for pH- and Thermo-Responsive Gentamicin Delivery and Antibacterial Activity.
Article in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infected wounds require localized antimicrobial treatment strategies that provide sustained drug release, reduce systemic antibiotic exposure, and promote tissue repair. This study reports an infection-responsive nanocomposite hydrogel platform based on dynamic covalent boronic ester chemistry for triggered topical antibiotic delivery. Phenylboronic acid (PBA)-functionalized cationic nanoparticles (PBA-NPs) were employed as three-dimensional crosslinkers and combined with poly(vinyl alcohol) (PVA) to construct an injectable nanocomposite hydrogel via reversible boronic ester interactions. The nanocomposite hydrogel was characterized for morphology, injectability, rheological properties, stimuli-responsive behavior, in vitro antibiotic release, and antibacterial activity against Staphylococcus aureus and Pseudomonas aeruginosa. The resulting nanocomposite hydrogel exhibited a gel-sol transition at 39.7°C, while the pH-dependent chemistry of the boronic ester network supports enhanced network dissociation under mildly acidic conditions (pH 6.5). This dual pH- and thermo-responsive behavior enabled on-demand release of encapsulated gentamicin sulfate while preserving viscoelastic recovery consistent with dynamic network reconstruction. The cationic PBA-NPs exhibited intrinsic antibacterial activity and generated enhanced antimicrobial effects when combined with gentamicin. Zones of inhibition reached 22 mm (S. aureus) and 25 mm (P. aeruginosa) at 3% drug loading. Collectively, these findings demonstrate that dynamic covalent boronic ester nanocomposite hydrogel represents a promising injectable platform for infection-responsive localized antibiotic delivery and antibacterial wound management.
Indexed as
Identifiers
42881279What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.